Advertisement
U.S. markets closed

NLS Pharmaceutics Ltd. (NLSP)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
0.1800+0.0100 (+5.88%)
At close: 04:00PM EDT
0.1799 -0.00 (-0.06%)
After hours: 04:16PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Intermediate-term KST

Intermediate-term KST

Previous Close0.1700
Open0.1689
Bid0.1700 x 100
Ask0.1750 x 200
Day's Range0.1680 - 0.1900
52 Week Range0.1400 - 1.6000
Volume659,404
Avg. Volume519,767
Market Cap7.121M
Beta (5Y Monthly)-0.72
PE Ratio (TTM)N/A
EPS (TTM)-0.5000
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est6.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NLSP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NLS Pharmaceutics Ltd.
    Daily – Vickers Top Buyers & Sellers for 01/12/2024The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Rating
    Fair Value
    Economic Moat
    2 months agoArgus Research
View more